Colorectal Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 or older, of any gender.
- People who weigh at least 55 kg at the time of joining.
- People who are willing and able to sign a consent form.
- Group 1: People who have colorectal cancer that has spread to the lining of the abdomen (peritoneal metastases), confirmed by laboratory testing, where the spread occurred either at the same time as the original diagnosis or after it, and where surgery to remove the spread is considered an option — this group excludes a specific tumour type where more than 30% of cells are a mucus-producing type (confirm with trial site).
- Group 2: People who have colorectal cancer (further details to confirm with trial site).
- Group 3: People who have a long-term inflammatory condition that is not related to cancer (confirm with trial site).
- Group 4: People who have a long-term non-cancer inflammatory condition and are having planned abdominal wall repair surgery or planned removal of part of the large bowel for a condition called diverticulosis.
- Group 5: People who have an abdominal infection condition, such as a perforated bowel causing peritonitis, non-perforated appendicitis, or gallbladder inflammation — all in a non-cancer context.
Who may not be able to join:
- People who currently have an active cancer other than colorectal cancer.
- People who have a progressive autoimmune disease (a condition where the immune system is actively attacking the body and worsening over time).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +33 478 862 371
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Kinetic of nucleosome and CCCTC-binding factor (CTCF)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.